Con artists John Lim is likely still increasing his compensation for the year while he lays off his crew without batting an eyelash.
D
Sorry but Ersaca is going the same way as Kaleido. to zero
j
Look at their pipeline. An ERK inhibitor is their frontrunner? Erk is in every cell not just tumors. This is gonna be dropped and then watch it'll drop silently off their website without making public announcement.